Latest News - Roper Technologies

Top Corporates Hub

Roper Technologies

ROP | NASDAQ | United States
334
-39
Rank
$59.99B
Market Cap
$7.03B
+$ 0.86B
+13.94%
Revenue
$1.96B
+$ 0.22B
+12.64%
Earnings
18.2K
+1.4K
+8.33%
Employees
Roche Holding (SWX:ROP) Ebola Testing Support Keeps Fair Value In Focus

09.10.2026 00:20

Roche Holding (SWX:ROP) has been back in focus after Roche Diagnostics shipped two molecular testing instruments to support Ebola response efforts in the Democratic Republic of Congo, tying humanitarian work directly to the diagnostics segment. Against this backdrop, Roche Holding shares trade at CHF352.7 after a 1-day share price return that declined 2.03%. The 90-day share price return of 4.78% and 1-year total shareholder return of 23.81% indicate that momentum has been gradually building...

Read More

Roper Technologies (ROP) Adds AI Expertise On The Board As Fair Value Debate Builds

07.10.2026 16:13

Board shake-up puts fresh AI expertise on Roper Technologies under investor focus Roper Technologies (ROP) has drawn fresh attention after appointing Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, to its Board of Directors effective October 1, 2026. The move arrives as investors already watching Roper Technologies for its compressed valuation and cash generation now consider how Dubey’s enterprise AI background could inform the company’s software heavy portfolio and...

Read More

Roper (ROP): Are Buybacks a Better Use of Cash than More Acquisitions?

07.10.2026 14:21

Roper Technologies, Inc. (NASDAQ:ROP) spent $3.2 billion repurchasing shares over three quarters as software acquisition opportunities became harder to justify. Specialized workflows create switching costs, but artificial intelligence is increasing development demands across software. Buying more of an established business can improve shareholder returns, provided financing costs do not consume the benefit. Roper Technologies, Inc. […]

Read More

Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC

07.10.2026 05:00

As the outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of Congo (DRC), demand for testing is exceeding current available laboratory capacity, and strategic public-private partnerships are powering rapid testing and a more effective disease response. As a result, Roche Diagnostics has committed to reinforcing local laboratory testing capacity and training laboratory staff to boost essential testing capacity.1

Read More

3 European Defensive Stocks Investors Are Watching As Bond Markets Turn Risk Off

03.10.2026 13:10

Bond markets are throwing out fresh stress signals, with investors racing toward German Bunds and dumping riskier debt across Europe. That kind of flight to safety can punish cyclical stocks and fragile balance sheets, yet it can also shine a harsh but helpful spotlight on sturdier businesses. This article explores 3 Core European Defensive Equities that are closely exposed to this bond shock and explains why their reactions might matter for your portfolio decisions now. The three stocks...

Read More

Roche launches newborn screening test for three severe genetic conditions

30.09.2026 05:00

Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an in vitro diagnostic test for newborn screening in countries accepting the CE mark. The test simultaneously screens for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD). This launch provides a crucial, ready-to-use solution for private and academic hospital labs, enabling the ea

Read More

Best Dividend Aristocrats For October 2026

28.09.2026 00:56

The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.

Read More

Is Roche Holding (SWX:ROP) Undervalued Following Its Phase 3 IgA Nephropathy Win?

23.09.2026 19:14

Roche Holding (SWX:ROP) is back in focus after partner Ionis reported that sefaxersen met the primary endpoint in the Phase 3 IMAgINATION trial for IgA nephropathy, delivering a statistically significant reduction in proteinuria compared with placebo. The latest clinical headlines come on top of a strong run for Roche Holding, with the share price up 8.32% over 90 days and 11.58% year to date. The 1-year total shareholder return of 44.02% points to momentum that has been building rather than...

Read More

DAT: Spot van rate falls 20 cents in steepest August pullback on record

15.09.2026 13:30

PORTLAND, Ore., Sept. 15, 2026 (GLOBE NEWSWIRE) -- National average truckload spot rates fell across all three equipment types in August, posting the steepest July-to-August declines in DAT’s 16-year rate history, according to DAT Freight & Analytics, provider of the industry’s leading load boards and freight analytics. The pullback also moved dry van and refrigerated (“reefer”) spot rates back below contract rates after spot rates exceeded contract rates in June and July. Spot rates post record

Read More

Roper Technologies, Inc. (ROP) Presents at Piper Sandler 5th Annual Growth Frontiers Conference Transcript

15.09.2026 12:31

Roper Technologies, Inc. (ROP) Piper Sandler 5th Annual Growth Frontiers Conference September 15, 2026 9:30 AM EDTCompany ParticipantsJason Conley -...

Read More

Roche (SWX:ROP) Stock Looks Reasonable On Earnings But Mixed On Value

06.09.2026 08:10

Roche Holding stock has delivered a solid multi year gain, yet the valuation signals are more mixed, which leaves investors weighing a strong price record against a less clear cut verdict on how cheap the shares really are. After a 3 year climb, the stock now screens as neither an obvious bargain nor clearly expensive. Roche Holding has returned about 54.2% over the past 3 years, which puts extra focus on whether that share price performance already reflects most of the good news in the...

Read More

Why Is Leidos (LDOS) Up 5.5% Since Last Earnings Report?

03.09.2026 15:30

Leidos (LDOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Read More

Roper Technologies to present at Citi Technology Conference

03.09.2026 13:30

SARASOTA, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Citi Global TMT Conference on Thursday, September 10, 2026, at 8:50 AM (Eastern Time). A link to the webcast presentation will be available in the “Investors” section of the Company’s website at www.ropertech.com. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 500. Roper has a proven, long-term track record of compo

Read More

Roper Technologies to present at Goldman Sachs Technology Conference

02.09.2026 13:30

SARASOTA, Fla., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Goldman Sachs Communacopia + Technology Conference on Wednesday, September 9, 2026, at 8:10 AM (Pacific Time). A link to the webcast presentation will be available in the “Investors” section of the Company’s website at www.ropertech.com. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 500. Roper has a proven, long-te

Read More

Is Roche Holding (SWX:ROP) Fully Valued After Its Latest US Manufacturing Push?

22.08.2026 00:12

Genentech’s plan to invest $750 million in a new device fill finish facility in Hillsboro, Oregon, has put Roche Holding (SWX:ROP) back in focus for investors watching its U.S. manufacturing footprint. See our latest analysis for Roche Holding. Roche Holding’s recent manufacturing announcements have landed against a strong run in the stock, with a 13.0% 1 month share price return and a 15.4% year to date share price return, while the 1 year total shareholder return of 48.0% points to building...

Read More

Roper Technologies (NASDAQ:ROP) Flashes Bull Flag Breakout Setup Amid Strong Technical Trend

17.08.2026 11:41

ROPER TECHNOLOGIES (ROP) shows a strong technical setup with a 7/10 rating and bull flag pattern, offering a defined breakout entry above $408.09.

Read More

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

06.08.2026 11:59

Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits on several high-profile names while upgrading others to buy. Find out which stocks got the most surprising treatment before the opening bell.

Read More

Roper Technologies to present at Oppenheimer Technology Conference

04.08.2026 12:30

SARASOTA, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Oppenheimer 29th Annual Technology, Internet & Communications Conference on Tuesday, August 11, 2026, at 9:55 AM (Eastern Time). A link to the webcast presentation will be available in the “Investors” section of the Company’s website at www.ropertech.com. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 500. Roper has

Read More

Illumia Appoints Eric Schuster as Chief Product Officer

30.07.2026 14:00

SCOTTSDALE, Ariz., July 30, 2026--Illumia, a leading provider of technology solutions that power payments, identity, commerce, and foodservice operations across higher education, healthcare, and corporate campuses, today named Eric Schuster as Chief Product Officer.

Read More